Title : TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer.

Pub. Date : 2021 Oct 2

PMID : 34598710






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Mechanistically, the PI3K/AKT signaling pathway was activated in cisplatin-resistant cells, and this pathway would be affected by TTK expression. Cisplatin AKT serine/threonine kinase 1 Homo sapiens